CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
10 hedge funds and large institutions have $24.2M invested in Celyad Oncology SA American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+3
Holders Change %
+42.86%
% of All Funds
0.15%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
6
Increased
1
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
FIG
Fortress Investment Group
New York
|
+$23.8M |
2 |
HF
HRT Financial
New York
|
+$139K |
3 |
TSS
Two Sigma Securities
New York
|
+$65K |
4 |
Jane Street
New York
|
+$44K |
5 |
Wells Fargo
San Francisco,
California
|
+$40.2K |
Top Sellers
1 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$596K |
2 |
![]()
JPMorgan Chase & Co
New York
|
-$12K |
3 |
Morgan Stanley
New York
|
-$3.17K |
4 |
UBS Group
Zurich,
Switzerland
|
-$2.95K |
5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.52K |